Roundhill Cannabis ETF

WEED

Börsenwert 6,6 Mio. $

Despite a broad market selloff driven by rate-hike fears, a handful of ETFs delivered double-digit gains last week.

One hundred days into the Iran war, AI, shipping and cannabis ETFs have surged, while crypto, bonds and gold miners lagged.

Medical marijuana's US reclassification revives cannabis ETFs like WEED, with tax relief and reform hopes fueling sharp gains across the sector.

April's ETF winners surged on oil rally, AI boom and strong earnings. Hydrogen, semis, AI, meme and cannabis funds led the charge.

Cannabis stocks have seen renewed investor interest as federal policy momentum improves. The most important recent development was the placement of FDA-approved marijuana products and state-regulated medical marijuana products from Schedule I to Schedule III under the Controlled Substances Act.

Cannabis, semis, crude & hydrogen ETFs led last week as AI momentum, policy boost and Middle East tensions shaped market trends.

Canopy Growth Corporation (WEED:CA) Q3 2026 Earnings Call Transcript

The Roundhill Cannabis ETF (BATS: WEED) has posted a dramatic surge in technical strength, with its momentum ranking jumping to the 89th percentile this week amid renewed optimism for federal cannabis reform.

Santa Rally fizzled as markets stumbled, but ETFs tied to cannabis (MSOS, WEED), metals (SLV, PPLT) and space (UFO) surged.

I recommend buying cannabis sector ETFs. Recent news suggests imminent U.S. regulatory easing, potentially reclassifying marijuana and unlocking significant sector value. Current MJ ETF price/sales is 1.5x; I conservatively project a move to 2.5x, implying 66% upside. Key risks include regulatory uncertainty, sector profitability challenges, and historical underperformance post-IPOs.